We talk about molecular testing with Dr. Andrzej Tysarowski, head of the Department of Genetic and Molecular Cancer Diagnostics at the National Cancer Institute.
For more than two years, we have been talking about the need for an additional benefit in the form of comprehensive genomic profiling. For whom are these tests necessary?
This is a genetic test, quite advanced, dedicated to specific clinical situations. It is not necessary to implement this service in all oncology patients, while in selected groups, such as patients with ovarian cancer or patients with lung cancer, such testing is most applicable. It can be said that it is even necessary in them in order to properly select therapy and properly conduct the entire treatment process....
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
